A novel ferroptosis-related signature for predicting prognosis, immune characteristics, and treatment prediction in hepatocellular carcinoma
Fig 13
The relationship between nFGRs and their risk subgroups in the immune environment and immune therapy response.
(A) Correlation analysis of nFGRs and immune infiltrating cells; (B) Comparison of immune checkpoint expression between the high-risk and low-risk groups; (C) Differences in StromalScore between the high-risk and low-risk groups; (D) Differences in TIDE scores between the high-risk and low-risk groups. (E)Differences in IPS between the high-risk and low-risk groups.